![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_7a35ec1091778db6d43ef7ac4973500d.svg) | (2S,3R)-3-(2,2-Dimethylpropyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-pentan-3-ylbutanediamide | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_3524489501536cc2023d4ddc4ca6824e.svg) | (2S,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-pentan-3-yl-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_e076aabce3b0787ce2b81d48078e3f3f.svg) | (2S,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-propyl-3-(2,2,2-trifluoroethyl)butanediamide | IC50 | 24.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_26574666c81f0f5ab8289b950e9d9fb8.svg) | (2R,3R)-2-(1,2,4-Oxadiazol-3-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 656.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_001b3893e94b52d313c1c559e7850e0b.svg) | (2R,3R)-2-(1,3-Oxazol-4-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 161.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_97edd0215cd6210438a5f1ccb7be883c.svg) | (2R,3R)-2-(1,2-Oxazol-4-yl)-N'-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 29.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_3cb25a6c8f5bdc18e6b021edb00f1c53.svg) | (2R,3R)-2-(5-Methyl-1,2,4-oxadiazol-3-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 119.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_21ef2d2c8c7a3f58ef45c45ac3ad2405.svg) | (2R,3R)-2-(5-Methyl-1,2-oxazol-3-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 62.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_80b8840d778565292509a73ae3903987.svg) | (2R,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-(3-methylphenyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_6b6c98cc8277c4ed8db93386732dbe9b.svg) | (2R,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-[3-(trifluoromethyl)phenyl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_e393777ab223730606e49c8a73d155d7.svg) | (2R,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-[3-(trifluoromethoxy)phenyl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_37a79ae4e4b839d4e0a0b1044e29ce77.svg) | (2R,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-(3-methylsulfonylphenyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 2241.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_cd80eebfa10a4da9fdb4e6bf2f7d935b.svg) | (2R,3R)-2-(4-Methoxyphenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 6.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_4527afd510a2136a41735df617397f93.svg) | (2R,3R)-2-(3,4-Difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_880896f6f4bf41ea35e0be8bee64d0da.svg) | (2R,3R)-2-(2,4-Difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_c74d2cf13e7797de92b11897414fce63.svg) | (2R,3R)-2-(3,5-Difluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_6434d05608a1cbf9bb19df65baa9d6fa.svg) | (2S,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(2-methylpropyl)-2-pentan-3-ylbutanediamide | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_3c416130a9badef1621bd88557753765.svg) | (2R,3R)-N'-[(3S)-1-Methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenyl-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_e9a915fa817d7881ccfe806b69984962.svg) | Unii-lsk1L593UU | IC50 | 8.5 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_48689de90ffc3c819db03a19eff4351b.svg) | (2R,3R)-2-(4-Fluorophenyl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_e52f188940e41cfb7b8ccb2a16e97281.svg) | (2R,3R)-2-(3-Methyl-1,2-oxazol-4-yl)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_e8a97ebae124eee0039722f6abc9f604.svg) | (2S,3R)-N'-[(3S)-5-(3-Chlorophenyl)-9-ethyl-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.3 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_65b4c3fb1a6588ff73634208c2b419e6.svg) | (2S,3R)-N'-[(3S)-5-(3-Chlorophenyl)-2-oxo-9-propan-2-yl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 1.9 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_e122c5bc8f2259de3e0cc0d3b2703fa7.svg) | (2S,3R)-N'-[(3S)-9-Ethyl-5-(3-methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.5 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_aeb367a5d4771b5245329963ee1315dd.svg) | (2S,3R)-N'-[(3S)-5-(3-Chlorophenyl)-9-methyl-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_5c35796bb5dda427ee4900fc18998079.svg) | (2S,3R)-N'-[(3S)-5-(3-Chlorophenyl)-9-methyl-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(4,4,4-trifluorobutyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 11.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_eef949047878a7ce4c18bef17560e1da.svg) | (2S,3R)-N'-[(3S)-5-(3-Methylphenyl)-2-oxo-9-(trifluoromethyl)-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_9fa85c2f74b1e178506c24368479384c.svg) | (2S,3R)-N'-[(3S)-9-Chloro-5-(3,5-dimethylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 5.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_fd01ba91afd535c298f2dbbdd563ee11.svg) | (2S,3R)-N'-[(3S)-5-(3-Methylphenyl)-2-oxo-9-propan-2-yl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 3.2 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_14c05afc0c5438f106ef3d314fbc55dc.svg) | (2S,3R)-N'-[(3S)-2-Oxo-5-phenyl-9-propan-2-yl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.9 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_473592fd42e88e2882e865a8a362f44c.svg) | (2S,3R)-N'-[(3S)-9-Cyclopropyloxy-5-(3-methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(4,4,4-trifluorobutyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 12.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_c22204757905431c61f2ce0d29f09a75.svg) | (2S,3R)-N'-[(3S)-9-Cyclopropyloxy-5-(3-methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_edf548defc13dde8267c700a84c108cb.svg) | (2S,3R)-N'-[(3S)-9-Cyclopropyloxy-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(4,4,4-trifluorobutyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 3.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_ca391d91bb4955590dc17d72ef95641b.svg) | (2S,3R)-N'-[(3S)-9-Chloro-5-(3-methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(4,4,4-trifluorobutyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 2.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_c8bfa0abde0d250546890bd512ad0cad.svg) | (2S,3R)-N'-[(3S)-9-Methyl-2-oxo-5-[3-(trifluoromethyl)phenyl]-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(4,4,4-trifluorobutyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 7.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_a5696dbece61965b37769e1f81a4d2cd.svg) | (2S,3R)-N'-[(3S)-9-Cyclopropyloxy-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_f15e3c680bf9290f173eb16aeead0b31.svg) | (2S,3R)-N'-[(3S)-9-Methyl-2-oxo-5-[3-(trifluoromethyl)phenyl]-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 1.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_b3236e5ef8b5e3b6342a1f91433cf05a.svg) | (2S,3R)-N'-[(3S)-9-Chloro-5-(2-methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 6.1 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_359165f0ea30a658b581abfe69d641f8.svg) | (2S,3R)-N'-[(3S)-5-(4-Fluorophenyl)-9-methyl-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 6.3 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_2cf6f39fb23197d278be43a7c912cfde.svg) | (2S,3R)-N'-[(3S)-9-Methyl-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 8.3 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_30b36764336279c07337c62363fd0e12.svg) | (2S,3R)-N'-[(3S)-9-Cyclopropyl-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 2.1 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_9e7d123a531dcd96fb8dd8ac44eb2448.svg) | (2S,3R)-N'-[(3S)-9-Chloro-5-(3-cyclopropylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 2.9 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_e54ff0e5a8effd4aec1afdac5824b701.svg) | (2S,3R)-N'-[(3S)-5-(3-Chlorophenyl)-9-methoxy-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 3.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_3d522005c317069b26864c8e2ea01e14.svg) | (2S,3R)-N'-[(3S)-5-(4-Chlorophenyl)-9-methoxy-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 2.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_af2621f9d75e3cb57ebfb4b402037d5a.svg) | (2S,3R)-N'-[(3S)-9-Chloro-5-(3-methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 7.2 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_2dfe1271fd90b75025b08101d2aeffc4.svg) | (2S,3R)-N'-[(3S)-9-Methoxy-5-(3-methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 5.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_4a4a8cb25398a12ad8f5b987ff9b9b6b.svg) | (2S,3R)-N'-[(3S)-5-[4-(Hydroxymethyl)phenyl]-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 7.9 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_f873f95e092f94cf7745fa38f84575b9.svg) | (2S,3R)-N'-[(3S)-5-(2-Methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_82bd74205068c51a9705d8c3ef22c3af.svg) | (2S,3R)-N'-[(3S)-5-(3-Methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 6.1 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_ad88be82eb1fb97908dd1983be7428a4.svg) | (2S,3R)-N'-[(3S)-9-Methoxy-2-oxo-5-[5-(trifluoromethyl)pyridin-2-yl]-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 7.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_4253b703a0b473114faaa11a3ff0d137.svg) | (2S,3R)-N'-[(3S)-5-(5-Chloropyridin-2-yl)-9-methoxy-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 13.4 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_a348197074c8c39a436280950d75afd1.svg) | (2S,3R)-N'-[(3S)-5-(4-Methylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_6ef5170c7f2c58d550759f0104eac7d6.svg) | (2S,3R)-N'-[(3S)-5-(3-Fluorophenyl)-9-(hydroxymethyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide | IC50 | 9.3 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_3d175613a2f0fd324fdd4ed5d4147fec.svg) | (2S,3R)-N'-[(3S)-9-Chloro-5-(3,5-dimethylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(4,4,4-trifluorobutyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neurogenic-locus-notch-homolog-protein-3_929b2dd543fc98ab93ade349157b1bd4.svg) | (2S,3R)-N'-[(3S)-9-Chloro-5-(3,4-dimethylphenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2-(4,4,4-trifluorobutyl)-3-(3,3,3-trifluoropropyl)butanediamide | IC50 | 7.3 [1] |